Latin Amern Minerals (LATNF) 0.2754

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Latin Amern Minerals (LATNF) 0.2754 $LATNF

Reconfiguration of the Gold Processing Plant at the Independencia Mine has Commenced
TheNewswire.ca - Tue Aug 02, 7:00AM CDT
(via Thenewswire.ca)
LAT.VN: 0.380 (+0.010)

Latin American Announces Effective Date of Consolidation
Marketwired - Wed Dec 30, 4:08PM CST
Latin American Minerals Inc. (TSX VENTURE: LAT) (the "Company" is pleased to announce that the consolidation of the common shares of the Company (the "Common Shares" on the basis of one (1) post-consolidation Common Share for every ten (10) pre-consolidation Common Shares (the "Consolidation", will become effective on December 31, 2015. The Company has received final acceptance by the TSX Venture Exchange ("TSVX" to effect the Consolidation. The post-Consolidation Common Shares are expected to begin trading on the TSXV at the opening of market on December 31, 2015, under the existing stock symbol "LAT". A new CUSIP number has been obtained to replace the previous CUSIP number in order to distinguish the pre-Consolidation Common Shares and the post-Consolidation Common Shares.
LAT.VN: 0.380 (+0.010)

Latin American Announces Shareholder Approval of Consolidation
Marketwire Canada - Tue Dec 22, 3:30PM CST
Latin American Minerals Inc. (TSX VENTURE:LAT) (the "Company" announces that shareholders approved, among other things, the consolidation of the outstanding common shares (the "Shares" of the Company on a minimum of 8 pre-consolidation Shares and a maximum of 10 pre-consolidation Shares for 1 post-consolidation Share at a special meeting of its shareholders today. The directors of the Company have determined to consolidate the Shares on the basis of one (1) post-consolidation Share for every ten (10) pre-consolidation Shares outstanding on the effective date of the consolidation.
LAT.VN: 0.380 (+0.010)

Latin American Minerals Closes Final Tranche of Oversubscribed Private Placement Financing
Marketwired - Wed Nov 18, 2:08PM CST
Latin American Minerals Inc. (TSX VENTURE: LAT) (the "Company" or "LAT" announces the completion of the second and final tranche of a non-brokered private placement financing for gross proceeds of $1,566,962, exceeding the subscription target (the "Offering".
LAT.VN: 0.380 (+0.010)

Latin American Minerals Increases Private Placement to $1,500,000
Marketwired - Thu Oct 29, 7:48AM CDT
Latin American Minerals Inc. (TSX VENTURE: LAT) (the "Company" or "LAT" reports that due to the over-subscription of its previously announced $1,000,000 (October 6th 2015) non-brokered private placement of special warrants (the "Special Warrants", the Company is increasing the size of the private placement. The Company will now increase the issue by 50% to $1,500,000. Details of the Special Warrants can be found on the press release issued by Latin American Minerals on October 6th 2015.
LAT.VN: 0.380 (+0.010)

Latin American Minerals Closes First Tranche of $1,000,000 Private Placement
Marketwired - Mon Oct 26, 5:01AM CDT
Latin American Minerals Inc. (TSX VENTURE: LAT) (the "Company" or "LAT" announces the closing of the first tranche of a non-brokered private placement of special warrants (the "Special Warrants" at a price of $0.01 per Special Warrant (the "Purchase Price" for gross proceeds $719,500, subject to TSX Venture Exchange final approval (the "Offering". LAT issued 71,950,000 Special Warrants. The Special Warrants issued in connection with the completion of the first tranche of the Offering are subject to a hold period until February 24, 2016.
LAT.VN: 0.380 (+0.010)

Latin American Minerals Announces $1,000,000 Non-Brokered Private Placement
Marketwired - Tue Oct 06, 7:30AM CDT
Latin American Minerals Inc. (TSX VENTURE: LAT) (the "Company" announces that it intends to complete a private placement of special warrants (the "Special Warrants" at a price of $0.01 per Special Warrant (the "Purchase Price" for gross proceeds of up to $1,000,000 (the "Offering". Each Special Warrant is exchangeable, for no additional consideration, into one unit of the Company (each a "Unit". Each Unit is comprised of one common share of the Company (each a "Warrant Share" and one common share purchase warrant of the Company (each a "Warrant". Each Warrant entitles the holder thereof to purchase one Warrant Share for a period of three (3) years after the closing date of the Offering at a price of $0.015 per Warrant Share (subject to adjustment following the Consolidation (as defined below)).
LAT.VN: 0.380 (+0.010)

Latin American Minerals Closes $200,000 Financing, Announces Board Changes
Marketwired - Mon Aug 24, 7:28PM CDT
Latin American Minerals Inc. (TSX VENTURE: LAT) (the "Company" has completed a loan financing for gross proceeds of $200,000 for which the Company has issued $200,000 in promissory notes (the "Notes", with an interest rate of 12% per annum, secured by $200,000 in Value Added Tax ("VAT" credits owed to the Company's Paraguayan subsidiary Latin American Minerals Paraguay S.A., and other security. The Notes will mature on August 19, 2016 and may be prepaid at the Company's discretion with prior written notice. No finder's fees were paid in relation to the financing which is subject to regulatory approval. The net proceeds are to be used for general working capital purposes to address a short term working capital deficiency.
LAT.VN: 0.380 (+0.010)

Latin American Minerals Closes Private Placement Financing
Marketwired - Wed Jun 24, 7:40AM CDT
Latin American Minerals Inc. (TSX VENTURE: LAT) (the "Company" announces that it has completed a non-brokered private placement financing for gross proceeds of $332,900 and issued a total of 6,658,000 units at a price of $0.05 per unit.
LAT.VN: 0.380 (+0.010)

Latin American Minerals Announces Private Placement Financing
Marketwired - Thu Jun 11, 8:25PM CDT
Latin American Minerals Inc. (TSX VENTURE: LAT) (the "Corporation" announces that it intends to raise up to $350,000 by way of a non-brokered private placement financing, by issuing up to 7,000,000 units of the Corporation (the "Units" at a price of $0.05. Each Unit is comprised of one common share of the Corporation (a "Common Share" and one purchase warrant exercisable at $0.07 for a period of 36 months from the Closing Date (the "Offering". The proceeds of the financing will be used for general working capital purposes.
LAT.VN: 0.380 (+0.010)

Latin American Minerals Announces Closing of Financing
Marketwired - Thu Apr 30, 7:34AM CDT
Latin American Minerals Inc. (TSX VENTURE: LAT) (the "Company" announces that it has closed a financing under revised terms to those announced in the April 21, 2015 press release. The Company has issued $145,075 in promissory notes bearing simple interest at 1% per month. 4,145,000 share purchase warrants exercisable at $0.05 for a term of twenty four months will be issued in relation to this financing.
LAT.VN: 0.380 (+0.010)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Pan-Mass Challenge Gifts $80M to Dana-Farber for 2026

Updated Category News Views 135

A Momentous Gift in a Crunch Time for Cancer Research Biking and philanthropy might seem like an odd duo, but let me tell you, the Pan-Mass Challenge (PMC) is making that partnership look like peanut butter and jelly. This year, PMC rolled out a jaw-dropping $80 million gift to the Dana-Farber Cancer Institute. You heard right—eighty million smackeroos. Talk about going...

Continue Reading
Novo's CagriSema Trials Show Promising Weight Loss

Updated Category News Views 220

Decoding CagriSema's Promise Let me tell you, when those corporate folks from Novo Nordisk announce something big like their investigational drug CagriSema at ObesityWeek® 2026, it’s time to take notice. This isn’t just your average press release about some new weight loss fad. We’re talking about a phase 3 REDEFINE 1 trial that opens up a treasure chest of data...

Continue Reading
Portillo's Faces Class Action: Investor Losses at Stake

Updated Category News Views 210

Investor Tensions Rise as Portillo's Inc. Lawsuit Unfolds Investment ain't all sunshine and rainbows, and if you've been holding Portillo's Inc. (NASDAQ: PTLO) stocks between September 19, 2023, and May 4, 2026, you might find yourself caught in a storm front. We're talking shareholder class action lawsuit, folks, thanks to some allegedly misguided management moves. This...

Continue Reading
InstaHeat 35K: FOGATTI Offers Upgraded RV Furnace Control

Updated Category News Views 318

Winter RV Trips Just Got Cozier There's nothing quite like hitting the open road in an RV during the winter months. But let's face it, nobody wants to return to a cabin that's as frigid as the great outdoors. Here's where FOGATTI steps up its game with the InstaHeat Ultra 35K RV Furnace. They’ve tinkered with the thermostat to iron out more precise control, just in time...

Continue Reading
Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Updated Category News Views 269

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

Continue Reading
Uber Data Breach: Class Action Investigation Begins

Updated Category News Views 283

When Tech Meets Trouble: Uber's Data Breach Picture this: the hum of Uber rides weaving through your city, drivers none the wiser that personal info has been pried from the vaults thanks to their tech partner, Fireworks AI. Uber, folks, is in hot water once again. This isn’t just another tech hiccup; it's a legal whirlwind brewing up courtesy of Edelson Lechtzin LLP, a...

Continue Reading
WHO and RCSI Bahrain Join Forces on Health Initiatives

Updated Category News Views 406

Forging a Healthier Pathway In a world where healthcare challenges rise faster than my blood pressure during a stock market crash, the World Health Organization (WHO) and the Royal College of Surgeons in Ireland (RCSI) – Medical University of Bahrain have inked a deal to tackle these issues head-on. The memorandum of understanding (MoU) signed on November 15, 2026,...

Continue Reading
IDEAYA's IDE101: A New Front in Cancer Battle

Updated Category News Views 180

IDEAYA's Bold Move in Precision Medicine IDEAYA Biosciences, no stranger to the frontlines of cancer treatment, is gunning for a breakthrough with their latest pick, IDE101. They're jumping into the ring with a potential first-in-class inhibitor targeting CDKN2A-deficiency—a notorious player in the solid tumor game. They're not just mixing things up for the sake of it;...

Continue Reading
YONDELIS: Thai Approval Opens New Sarcoma Treatment Path

Updated Category News Views 103

New Hope for Thai Sarcoma Patients Alright, we’ve got some good news coming out of Thailand, folks. The Thai FDA just greenlit YONDELIS® (trabectedin) for those grappling with advanced soft tissue sarcoma (STS). Now, this isn’t your everyday drug release—it’s a clinical chess move packing potential for patients who’ve run out of other options. December 1st,...

Continue Reading
Investors Gear Up for Lennar Class Action Lawsuit

Updated Category News Views 235

High Stakes and Hard Hits for Lennar Stockholders There’s rarely a dull moment in the world of Wall Street, and Lennar Corporation (NYSE: LEN) is proving that rule right now. As a whiff of scandal wafts through the air, the famed homebuilder and its bigwigs are staring down the barrel of a formidable class action lawsuit. The question is, just how deep do the alleged...

Continue Reading

Top 5 Most Recently Viewed Articles

Kulicke & Soffa Announces Conference Call for Fiscal Results

Updated Category News Views 122

Kulicke & Soffa Schedules Conference Call Kulicke and Soffa Industries, Inc. (NASDAQ: KLIC), a leading name in semiconductor assembly technology, has announced a conference call to discuss its third fiscal quarter financial results and business outlook. The call is set for a future date, highlighting the company's commitment to transparency and communication with its...

Continue Reading
ARMOUR Residential REIT Launches Major Stock Offering for Growth

Updated Category News Views 162

ARMOUR Residential REIT Enters Public Stock Offering ARMOUR Residential REIT, Inc. (NYSE: ARR and ARR-PRC) has officially announced an underwritten public offering of 18,500,000 shares of common stock. The company is poised to grant underwriters an additional option to purchase up to 2,775,000 shares, making this a significant move for ARMOUR as it aims to enhance its...

Continue Reading
Celebrate Mother's Day with a Unique Brunch at Cannon + Belle

Updated Category News Views 195

Cannon + Belle Offers a Memorable Mother's Day Brunch Cannon + Belle at Hilton Austin is excited to announce an elevated Mother's Day brunch that promises to create unforgettable memories. This year, the restaurant will be hosting a special brunch event aimed at honoring mothers and all they do. With an impressive menu curated by the talented Chef Gereamy Cater, guests...

Continue Reading
Figma's Shares Surge in IPO But Valuation Remains a Concern

Updated Category News Views 244

Figma's Impressive IPO Performance Figma Inc. (NYSE: FIG) has captured significant investor attention following its explosive debut in the stock market. After launching its initial public offering, the company's shares skyrocketed by over 250%, marking a remarkable milestone for the firm. The stock began trading at a price of $33 per share, leading to approximately $1.2...

Continue Reading
Journey Medical Corporation's Emrosi Launch for Rosacea Relief

Updated Category News Views 215

Journey Medical Corporation Introduces Emrosi for Rosacea Treatment Journey Medical Corporation, a key player in the dermatological pharmaceutical industry, has recently launched Emrosi™ (40 mg Minocycline Hydrochloride Modified-Release Capsules), designed for the effective treatment of rosacea. The product, featuring a unique formulation of 10 mg immediate release and...

Continue Reading